Longevity Health Holdings Inc (NASDAQ: XAGE) is -42.96% lower on its value in year-to-date trading and has touched a low of $0.10 and a high of $2.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The XAGE stock was last observed hovering at around $0.18 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.16, the stock is 8.04% and -23.77% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.2 million and changing -10.51% at the moment leaves the stock -68.04% off its SMA200. XAGE registered -93.81% loss for a year compared to 6-month loss of -54.20%. The firm has a 50-day simple moving average (SMA 50) of $0.2089 and a 200-day simple moving average (SMA200) of $0.498215.
The stock witnessed a -28.55% gain in the last 1 month and extending the period to 3 months gives it a -70.05%, and is 24.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 29.61% over the week and 22.98% over the month.
Longevity Health Holdings Inc (XAGE) has around 15 employees, a market worth around $4.80M and $0.05M in sales. Profit margin for the company is -23456.30%. Distance from 52-week low is 59.20% and -94.57% from its 52-week high.
27.0 institutions hold shares in Longevity Health Holdings Inc (XAGE), with institutional investors hold 11.16% of the company’s shares. The shares outstanding are 30.12M, and float is at 22.68M with Short Float at 0.51%. Institutions hold 8.88% of the Float.
Longevity Health Holdings Inc (XAGE) Insider Activity
The most recent transaction is an insider purchase by Upton Richard A, the company’s Director. SEC filings show that Upton Richard A bought 5,000 shares of the company’s common stock on Sep 13 ’24 at a price of $0.47 per share for a total of $2336.0. Following the purchase, the insider now owns 15000.0 shares.
Longevity Health Holdings Inc disclosed in a document filed with the SEC on Sep 06 ’24 that Gregory Kathryn (Director) bought a total of 1,260 shares of the company’s common stock. The trade occurred on Sep 06 ’24 and was made at $0.51 per share for $643.0. Following the transaction, the insider now directly holds 22500.0 shares of the XAGE stock.
Still, SEC filings show that on Sep 06 ’24, Sturgeon Patrick A (Director) acquired 1,261 shares at an average price of $0.51 for $643.0. The insider now directly holds 18,051 shares of Longevity Health Holdings Inc (XAGE).
